Title
High Protein Breakfast on Postprandial Glycemia in T2D (PBD)
Effect of High Protein Breakfast on Overall Postprandial Glycemia in Type 2 Diabetes
Phase
N/ALead Sponsor
Hospital de Clinicas CaracasStudy Type
InterventionalStatus
Unknown statusIndication/Condition
Type 2 DiabetesIntervention/Treatment
Arm1: Whey protein ...Study Participants
60The investigators hypothesis is that eating whey protein in breakfast will reduce overall postprandial glycemia in individuals with type 2 diabetes (T2D).
It was shown that increasing protein at breakfast results in reduced overall postprandial glycemia in obese individuals This study was undertaken to evaluate whether compared to proteins like tuna, eggs and soy, the intake of whey protein in the breakfast is more effective to reduce overall postprandial glycemia (PPHG) in T2D individuals.
Arm1: Whey protein:The participants will consume 42 g protein, namely from Whey protein in the breakfast
Arm 2 Breakfast- other proteins: The participants will be assigned to 42 g protein of other protein sources at breakfast
Arm 3: Low protein' :The participants will consume 22 g protein at breakfast
In the Arm 1-Whey protein Breakfast the participant will consume 42 g protein at breakfast mainly from whey
In the Arm 2 Breakfast- other proteins sources (No Whey) the participants will consume 42 g protein from other sources (no Whey) at breakfast
In the Arm 3: breakfast with low proteins content, the participant will consume 22 g protein at breakfast
Inclusion Criteria: Participants: from 30 to 72 years of age BMI: 26 to 34 kg/m2) Diabetes criteria HbA1C: 7-9 % or Habitually eat breakfast Only naïve or treated with metformin. Not dieting and no change in body weight >10 lb = 4.5 kg within the last 3 months Normal liver, kidney and thyroid function. Exclusion Criteria: Type 1 Diabetes Anemia (Hg > 10 g/dL) Serum creatinine level < 1.5 mg/dl Pulmonary disease, psychiatric, immunological, neoplastic diseases or severe diabetic complications, such as cardiovascular disease, cerebrovascular disease, proliferative diabetic retinopathy, gastroparesis or underwent bariatric surgery. Abnormal liver function tests defined as an increase by a factor of at least 2 above the upper normal limit of alanine aminotransferase and/or aspartate Infectious disease Pregnant women or lactating Known hypersensitivity to milk components Documented or suspected history (within one year) of illicit drug abuse or alcoholism.